Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-01-30
2009-11-10
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S303000
Reexamination Certificate
active
07615532
ABSTRACT:
The present invention relates to insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the α-amino group of the N-terminal amino acid residue of the B chain or to the ε-amino group of a Lys residue present in the B chain of the parent insulin, the side chain being of the general formula:in-line-formulae description="In-line Formulae" end="lead"?-W-X—Y-Zin-line-formulae description="In-line Formulae" end="tail"?wherein W, X, Y and Z are as defined in the disclosure.
REFERENCES:
patent: 3528960 (1970-09-01), Haas
patent: 5898067 (1999-04-01), Balschmidt et al.
patent: 6251856 (2001-06-01), Markussen et al.
patent: 2002/0045731 (2002-04-01), Schaffer et al.
patent: 894095 (1997-02-01), None
patent: 0894095 (1999-02-01), None
patent: 1492997 (1976-07-01), None
patent: 91/12817 (1991-02-01), None
patent: 95/07931 (1994-09-01), None
patent: 98/02460 (1997-07-01), None
Havelund Svend
Hoeg-Jensen Thomas
Jonassen Ib
Madsen Peter
Ribel-Madsen Ulla
Novo Nordisk A S
Tate Christopher R.
Teller Roy
Walker Shelby J.
LandOfFree
Insulin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4061109